Myriad Genetics Inc (NASDAQ:MYGN)
| 18.65 Delayed Data As of 3:59pm ET |  +1.01 / +5.73%Today’s Change | 9.24 Today|||52-Week Range 30.13 | -31.51% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 17.64 |
| Today’s open | 17.83 |
| Day’s range | 17.60 - 18.80 |
| Volume | 35,662 |
| Average volume (3 months) | 696,479 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 11/24/2020
Growth & Valuation
| Earnings growth (last year) | -4,389.30% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -27.41% |
| Revenue growth (last year) | -24.97% |
| P/E ratio | NM |
| Price/Sales | 1.32 |
| Price/Book | 1.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LNTHLantheus Holdings In... | +0.38 | +2.95% |
| VIVOMeridian Bioscience ... | -0.28 | -1.59% |
| TRILTrillium Therapeutic... | -0.26 | -1.47% |
| CLDXCelldex Therapeutics... | +0.97 | +4.56% |
Data as of 3:59pm ET, 11/24/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $638.6M |
| Annual profit (last year) | -$199.5M |
| Net profit margin | -31.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
